This inventor holds 5 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh, Biopharm Gesellschaft Zur Biotechnolgischen Entwicklung Von Pharmaka Mbh, Charité – Universitätsmedizin Berlin. Active years: 2009-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 24 
1 out of 1 
1 out of 283 
Years Active: 2009-2015
Title: Michael Kruse: Innovator in Biosynthetic Growth Factors
Introduction
Michael Kruse is a notable inventor based in Mainz, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of biosynthetic growth factors. With a total of five patents to his name, Kruse's work has had a substantial impact on the industry.
Latest Patents
Among his latest patents are innovations related to high activity growth factor mutants. These inventions focus on novel biosynthetic growth factor mutants that exhibit improved biological activity. His work in this area has the potential to enhance various applications in biotechnology and medicine.
Career Highlights
Throughout his career, Michael Kruse has been associated with Biopharm Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka mbH. His expertise in the field has allowed him to contribute to the advancement of biopharmaceuticals and related technologies.
Collaborations
Some of his notable coworkers include Jens Pohl and Rolf Bechtold. Their collaborative efforts have furthered the research and development of innovative solutions in biotechnology.
Conclusion
Michael Kruse's contributions to the field of biosynthetic growth factors highlight his role as a leading inventor in biotechnology. His patents and collaborations reflect a commitment to advancing scientific knowledge and practical applications in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile